col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


44 Results       Page 1

 [1] 
Silicea - Poligraf, LLC: CARDIOVASCULAR THERAPY AND PREVENTION
  original article Date Title Authors   All Authors
1 [GO] 2022―Nov―05 Effect of spironolactone therapy on the activity of the matrix metalloproteinase system in patients with heart failure after COVID-19 V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, А. A. Ivannikov, et al. (+2)
2 [GO] 2022―Sep―08 Comparison of inhospital outcomes after open thrombectomy versus conservative therapy in patients with acute lower limb artery thrombosis and COVID-19 I. A. Abdullaev, S. V. Abasova, L. B. Danilchuk, V. A. Shramko, E. V. Sokolova, A. V. Korotkikh, et al. (+3)
3 [GO] 2022―Aug―11 Comparative efficacy of ivabradine and beta-blockers in the treatment of tachycardia in patients after COVID-19 V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, E. S. Ogibenina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov
4 [GO] 2022―Aug―11 Features of the pathogenesis and course of myocardial infarction in COVID-19 patients: a descriptive review M. G. Chashchin, A. Yu. Gorshkov, A. V. Strelkova, O. M. Drapkina
5 [GO] 2022―Jul―24 Assessment of the quality of research and practice events using telemedicine technologies at the National Medical Research Center for Therapy and Preventive Medicine during the COVID-19 pandemic O. M. Drapkina, R. N. Shepel, S. Yu. Astanina, T. V. Vakhovskaya, T. V. Sapronova, T. V. Samoilov
6 [GO] 2022―Jul―09 Russian-language publication activity of medical researchers in during the COVID-19 pandemic: “post-COVID-19 syndrome” O. T. Kim, O. M. Drapkina, Yu. V. Rodionova
7 [GO] 2022―Jul―09 New SARS-CoV-2 Omicron variant - clinical picture, treatment, prevention (literature review) V. I. Vechorko, O. V. Averkov, A. A. Zimin
8 [GO] 2022―Apr―07 Additional evidence against widespread use of inpatient antiplatelet therapy in coronavirus infection: data from a randomized controlled trial I. S. Yavelov
9 [GO] 2022―Mar―28 Place of renin-angiotensin-aldosterone system inhibitors and statins in the treatment of cardiovascular patients in the context of COVID-19 pandemic E. V. Sayutina, L. I. Butorova, E. M. Tuaeva, M. A. Osadchuk, M. M. Shamuilova
10 [GO] 2022―Mar―28 NEWS2, 4C Mortality Score, COVID-GRAM, Sequential Organ Failure Assessment Quick scales as outcomes assessment tools for severe COVID-19 (pilot retrospective cohort study) V. I. Vechorko, O. V. Averkov, D. V. Grishin, A. A. Zimin
11 [GO] 2022―Feb―28 Health care quality and changes in the clinical characteristics of patients with non-ST elevation acute coronary syndrome in a regional vascular center during the COVID-19 pandemic S. V. Dil, S. V. Demyanov, V. V. Ryabov, S. V. Popov
12 [GO] 2022―Feb―28 Use of non-steroidal anti-inflammatory drugs during the COVID-19 pandemic. Resolution of the Expert Council of the Russian Society for the Prevention of Noncommunicable Diseases O. M. Drapkina, S. N. Avdeev, A. V. Gorelov, V. P. Chulanov, L. I. Alekseeva, A. B. Danilov, et al. (+2)
13 [GO] 2022―Feb―28 Effusive pericarditis in the pathogenesis of cardiac arrhythmias in COVID-19: a case series Z. N. Sukmarova, M. A. Saidova, Yu. V. Ovchinnicov
14 [GO] 2022―Feb―28 Additional evidence against widespread use of inpatient antiplatelet therapy in coronavirus infection: data from a randomized controlled trial I. S. Yavelov
15 [GO] 2022―Jan―12 The possibilities of using antiplatelet agents during and after COVID-19 disease. Results of the Expert Council meeting Article Editorial
16 [GO] 2022―Jan―12 Dynamics of age characteristics and prevalence of concomitant cardiovascular and non-sardiovascular diseases in patients hospitalized with COVID-19 during epidemic wave: data from TARGET-VIP registry M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, et al. (+13)
17 [GO] 2022―Jan―12 The outpatient medical care in patients with chronic diseases under dispensary supervision in the conditions of the COVID-19 pandemic. Temporary guidelines. Version 2 O. M. Drapkina, L. Y. Drozdova, S. N. Avdeev, S. A. Boytsov, E. S. Ivanova, А. D. Kaprin, et al. (+8)
18 [GO] 2021―Nov―28 Association of COVID-19 lockdown measures with changes in physical activity of the adult population of Russia D. K. Mukaneeva, A. V. Kontsevaya, A. A. Antsiferova, I. N. Khalfiev, A. A. Seledtsov, E. A. Stolyarova, et al. (+4)
19 [GO] 2021―Nov―28 Clinical and anamnestic characteristics of patients with non-ST elevation myocardial infarction after COVID-19 M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina, I. V. Kositsyna, A. V. Golubev, N. I. Chaus, S. N. Perekhodov
20 [GO] 2021―Oct―16 Hydrogen inhalation in rehabilitation program of the medical staff recovered from COVID-19 L. V. Shogenova, Thi Tuet Truong, N. O. Kryukova, K. A. Yusupkhodzhaeva, D. D. Pozdnyakova, T. G. Kim, et al. (+11)
21 [GO] 2021―Oct―16 Single-center register of myocardial revascularization in patients with coronary artery disease and acute coronary syndrome in the context of COVID-19 pandemic O. V. Kamenskaya, A. S. Klinkova, I. Yu. Loginova, V. N. Lomivorotov, A. M. Chernyavskiy, V. V. Lomivorotov
22 [GO] 2021―Sep―12 COVID-19 as a cause of chronic pulmonary hypertension: pathophysiological rationale and potential of instrumental investigations E. Kobelev, T. A. Bergen, A. R. Tarkova, O. Ya. Vasiltseva, O. V. Kamenskaya, V. Yu. Usov, A. M. Chernyavsky
23 [GO] 2021―Sep―12 Acute coronary syndrome in COVID-19 patients M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina
24 [GO] 2021―Jul―18 Thrombectomy vs conservative therapy in patients with COVID-19 A. N. Kazantsev
25 [GO] 2021―Jul―18 COVID-19 and cardiovascular comorbidity: novel approaches to reduce mortality S. S. Bunova, P. I. Okhotnikova, Yu. P. Skirdenko, N. A. Nikolaev, O. A. Osipova, N. I. Zhernakova
26 [GO] 2021―Jul―18 Algorithms for adult outpatient care of coronavirus disease 2019 (COVID-19) and its Assumption M. A. Livzan, O. M. Drapkina, N. A. Nikolaev, Y. P. Skirdenko, R. N. Shepel, I. A. Viktorova, et al. (+15)
27 [GO] 2021―Jul―18 Acute lower limb ischemia in the context of the COVID-19 pandemic I. A. Vinokurov
28 [GO] 2021―Jul―18 Surgical thrombectomy versus conservative treatment in cases of acute limb ischemia with COVID-19 pneumonia A. M. Fahad, H. A. Alkhalidi, Y. Q. M. Altimimi
29 [GO] 2021―Jul―18 Mehman Mamedov: case management during and after coronavirus pandemic Article Editorial
30 [GO] 2021―May―15 COVID-19 from the interdisciplinary standpoint. Round table M. N. Mamedov, Yu. V. Rodionova, I. S. Yavelov, M. I. Smirnova, E. N. Dudinskaya, V. I. Potievskaya
31 [GO] 2021―May―15 Proteolytic enzyme and adiponectin receptors as potential targets for COVID-19 therapy K. A. Rubina, N. R. Sabitova, A. Yu. Efimenko, N. I. Kalinina, J. A. Akopyan, E. V. Semina
32 [GO] 2021―Feb―20 Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes T. Yu. Demidova, K. G. Lobanova, S. N. Perekhodov, M. B. Antsiferov, O. Sh. Oynotkinova
33 [GO] 2020―Dec―31 COVID-19 biobank: features of the cytokine profile N. N. Sushentseva, O. S. Popov, S. V. Apalko, A. Yu. Anisenkova, S. V. Azarenko, K. V. Smantserev, et al. (+8)
34 [GO] 2020―Dec―31 Prospective in-hospital registry of patients with suspected or documented COVID-19 infection and community-acquired pneumonia (TARGET-VIP): characteristics of patients and assessment of in-hospital outcomes O. M. Drapkina, O. E. Karpov, M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, et al. (+13)
35 [GO] 2020―Dec―31 Work within the COVID-19 pandemic - the experience of the biobank of the National Medical Research Center of Oncology I. V. Samokhina, A. B. Sagakyants
36 [GO] 2020―Jul―03 Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19 O. M. Drapkina, L. E. Vasilyeva
37 [GO] 2020―Jul―03 COVID-19 and nutrition: new emphases, old priorities (review of guidelines) N. S. Karamnova, O. M. Drapkina
38 [GO] 2020―Jul―03 Health promotion and prevention of chronic non-communicable diseases in the context of the COVID-19 pandemic. Consensus of experts of the National society of evidence-based pharmacotherapy and the Russian society of the prevention of non-communicable diseases O. M. Drapkina, M. G. Gambaryan, B. E. Gorny, N. S. Karamnova, A. V. Kontsevaya, N. K. Novikova, et al. (+3)
39 [GO] 2020―Jul―03 Tobacco smoking and COVID-19: an old enemy in a new guise. Review of current publications M. G. Gambaryan, O. M. Drapkina
40 [GO] 2020―Jul―03 COVID-19: urgent questions for estimating morbidity, prevalence, case fatality rate and mortality rate O. M. Drapkina, I. V. Samorodskaya, M. G. Sivtseva, E. P. Kakorina, N. I. Briko, S. N. Cherkasov, et al. (+2)
41 [GO] 2020―Jul―03 Novel coronavirus infection SARS-CoV-2 in elderly and senile patients: prevention, diagnosis and treatment. Expert Position Paper of the Russian Association of Gerontology and Geriatrics O. N. Tkacheva, Yu. V. Kotovskaya, L. A. Aleksanyan, A. S. Milto, A. V. Naumov, I. D. Strazhesko, et al. (+15)
42 [GO] 2020―Jun―25 Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020 V. B. Grinevich, I. V. Gubonina, V. L. Doshchitsin, Yu. V. Kotovskaya, Yu. A. Kravchuk, V. I. Ped, et al. (+6)
43 [GO] 2020―May―11 Self-monitoring and treatment of chronic non-communicable diseases in the context of the COVID-19 pandemic. Consensus of experts of the National society of evidence-based pharmacotherapy and the Russian society of the prevention of non-communicable diseases S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, L. P. Ivanova, N. A. Dmitrieva, et al. (+2)
44 [GO] 2020―May―11 COVID-19: hemostatic parameters and specifics of antithrombotic treatment I. S. Yavelov, O. M. Drapkina
 [1] 

44 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.007 sec